Among all 11,648 randomized patients ( both BMS and DES ) , stent thrombosis rates were 0.41 % vs 1.32 % ( n = 23 vs 74 ; HR , 0.31 ; 95 % CI , 0.19-0 .50 ; P < .001 ) , rates of MACCE were 4.29 % vs 5.74 % ( n = 244 vs 323 ; HR , 0.73 ; 95 % CI , 0.62-0 .87 ; P < .001 ) , and rates of moderate/severe bleeding were 2.45 % vs 1.47 % ( n = 135 vs 80 ; P < .001 ) .